“With adequate aging research support, we could be in reach of a breakthrough similar to those in public health in the 19th century and medicine in the 20th.”
Finding a way to slow the biological processes of aging will do more to extend the period of healthy life in humans than attacking individual diseases alone, according to some of the nation’s top gerontologists writing in the latest issue ofPublic Policy & Aging Report (PP&AR), titled “The Longevity Dividend: Geroscience Meets Geropolitics.” The authors showcase work in the emerging interdisciplinary field of geroscience, which is based on the knowledge that aging itself is the major risk factor for most chronic diseases prevalent in the older population.
The new PP&AR, published by The Gerontological Society of America (GSA), will be released during a November 22 press briefing at GSA’s 66th Annual Scientific Meeting in New Orleans. Both the issue and the briefing were developed in partnership with the American Federation for Aging Research.
“In recent years, researchers studying the biological underpinnings of the aging process have made impressive progress in understanding the genetics, biology, and physiology of aging,” said GSA Executive Director and CEO James Appleby, RPh, MPH. “With adequate research support, we could be in reach of a breakthrough similar to those in public health in the 19th century and medicine in the 20th.”
The PP&AR contains seven articles that discuss the contemporary pursuit of scientific means to extend the period of healthy life by slowing aging in people — known as the Longevity Dividend Initiative — and some of the obstacles that stand in the way of what many consider to be one of the most exciting breakthroughs in the history of science and public health.
“In this new issue, we are proud to spotlight the pioneering work of high-profile researchers who add visibility to the value of geroscience in the eyes of both the scientific community and the general public,” said AFAR Executive Director Stephanie Lederman, EdM.
As author Gordon J. Lithgow, PhD, points out, many childhood diseases were brought under control by antibiotics and vaccines once scientists understood they essentially had a single cause: microbes. If the diseases of late life also have a single cause (aging itself), then researchers should be able to develop classes of therapeutics by targeting aging mechanisms in a way similar to targeting microbial infection.
Yet PP&AR Editor Robert B. Hudson, PhD, explains that scientists may face difficulty in convincing skeptics — among the biomedical community, public and private funders of research, and the general public — that attacking aging is a viable and more efficient approach to reducing the risk of all fatal and disabling diseases and improving well-being across the life cycle.
Author S. Jay Olshansky, PhD, additionally emphasizes that the Longevity Dividend Initiative is not focused on delaying aging at the expense of an extended period of infirmity at the end of life. He writes that “although people who benefit from advances in aging science will probably live longer, the extension of healthy life is the primary goal. In addition, reductions in the infirmities of old age and increased economic value to individuals and societies would accrue from the extension of healthy life.”
The Latest Google Headlines on:
The Latest Bing News on:
- Aging Research Dayon November 24, 2020 at 4:00 pm
Aging Research Day is on Wednesday, May 15, and the Keynote speaker is Dr. Matthew Kaeberlein (Title: Translational geroscience: Targeting mTOR to promote healthy longevity) from the University of ...
- Health Benefits of Astaxanthinon November 13, 2020 at 11:01 am
GeroScience: “Neuroprotective mechanisms of astaxanthin: a potential therapeutic role in preserving cognitive function in age and neurodegeneration.” Journal of Allergy and Clinical Immunology ...
- UB Exceptional Scholars: Sustained Achievement Awardon October 28, 2020 at 5:46 am
A thought leader in aging-related geroscience and molecular biology and regional leader in geriatric care, Dr. Troen founded and directs the Center of Excellence for Alzheimer's Disease of WNY and the ...
- Rosita Longevity wants to teach seniors how to live long, healthy liveson October 15, 2020 at 1:12 am
That will become our Habits Engine. Together with our geroscience research plan, those are the uncertainties to get right with our current funding." Targeting chronic pain is another key aim for the ...
- Rosita Longevity wants to teach seniors how to live long, healthy liveson October 15, 2020 at 12:27 am
That will become our Habits Engine. Together with our geroscience research plan, those are the uncertainties to get right with our current funding." Targeting chronic pain is another key aim for ...
- About the Divisionon August 17, 2020 at 2:45 am
Jeffrey Pessin and Ana Maria Cuervo to chair panels at the first symposium on "geroscience"—the study of how aging influences the onset of chronic diseases. Dr. Colette Knight to Lead New Wakefield ...
- Boomers in the next decade: Working longer, living betteron January 16, 2020 at 2:18 pm
Another potential development: the search for therapies that might slow aging by targeting underlying molecular, cellular and biological processes — a field known as “geroscience.” ...
- Aging Is Not Optional. Or Is It?on January 3, 2020 at 4:28 pm
In geroscience, we seek to understand the relationship between aging, disease, and quality of life. The promise of this field is that by intervening in the process of aging, we could slow, prevent, ...
- I want my dog to live longeron July 9, 2018 at 8:09 am
Geroscience is the biology of aging, and researchers have made tremendous strides in slowing aging and extending the lifespan of smaller mammals. The Dog Aging Project is in its second year of ...
The Latest Google Headlines on:
The Latest Bing News on:
- Lessons from aging Japan: losing vibrancy with few structural reformson November 27, 2020 at 4:10 am
As well known, Japan has one of the fastest aging population in the world, reducing the size of the working age population. On the one hand, because labor participation declines significantly beyond ...
- Amorepacific Develops an Original Technology That Reverses the Aging of Skin Cells in Joint Research with KAISTon November 26, 2020 at 11:12 pm
Amorepacific R&D Center, together with KAIST, developed an original technology that reverses the aging process in human dermal fibroblasts. The system’s biology research was conducted in collaboration ...
- Anti-Aging Products and Therapies Market Size to Surpass US$ 16630 million By 2025on November 26, 2020 at 3:53 am
Aging Products and Therapies Market Report added at Market Study Report LLC offers industry size, share, growth, trends and forecast analysis up to 2025. Anti-Aging Products and Therapies Market ...
- Exposure to Outer Space May Accelerate Aging, New Evidence Suggestson November 25, 2020 at 1:00 pm
A fascinating batch of new research papers highlight the various health risks associated with long-duration space missions, including troublesome observations having to do with the aging process and ...
- Research provides new insights on health effects of long-duration space flighton November 25, 2020 at 8:02 am
The historic NASA Twins Study investigated identical twin astronauts Scott and Mark Kelly and provided new information on the health effects of spending time in space.
- The FDA has approved the first drug to treat the rapid-aging disease progeriaon November 25, 2020 at 3:03 am
Children with a rare genetic disorder called progeria age quickly and often die before they are 15. A newly approved drug may give them more time.
- November 2020: Happiness Research to Support Aging Societieson November 24, 2020 at 3:43 pm
Aging populations face a particular set of challenges in preserving well-being and in decreasing the cost of age-related illnesses. Recognizing the relationship between these challenges, Drs.
- PowerFlex Completes EV Charging System for Buck Institute for Research on Agingon November 24, 2020 at 11:10 am
PowerFlex-an EDF Renewables Company completed the installation of 49 electric vehicle (EV) charging stations for the Buck Institute for Research on Aging. The EV chargers provide Buck employees with a ...
- Anti-aging biotech Elevian raises $15M as it looks to the clinicon November 24, 2020 at 6:05 am
Early-stage biotech Elevian has raised $15 million as it looks to target multiple age-related diseases. The Allston, Massachusetts-based company said the small raise would help its preclinical work ...
- Another Win for Senolytics: Fighting Aging at the Cellular Level Just Got Easieron November 24, 2020 at 6:00 am
Senolytics, the drug that wipes out senescent cells and a darling candidate for prolonging healthspan, may also be able to rescue cells' energy production.